Elekta AB 

€5.50
82
-€0.01-0.18%Friday 07:16

Statistics

Day High
5.5
Day Low
5.5
52W High
5.85
52W Low
3.73
Volume
-
Avg. Volume
-
Mkt Cap
2.03B
P/E Ratio
-
Dividend Yield
3.94%
Dividend
0.22

Upcoming

Dividends

3.94%Dividend Yield
Sep 2026
€0.11
Mar 2026
€0.11
Sep 2025
€0.11
Mar 2025
€0.11
Sep 2024
€0.11
10Y Growth
23.63%
5Y Growth
15.25%
3Y Growth
1.62%
1Y Growth
0.08%

Earnings

Nov 25Expected
Q4 2025
Q1 2026
Q2 2026
Next
0.04
0.07
0.1
0.13
Expected EPS
0.07722383943568
Actual EPS
N/A

Financials

-3.09%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
1.54BRevenue
-47.55MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow EJXB.MU. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Medtronic
MDT
Mkt Cap123.49B
Medtronic competes with Elekta in the neurosurgical market, offering products for brain surgeries and pain management that overlap with Elekta's Gamma Knife radiosurgery systems.
Intuitive Surgical
ISRG
Mkt Cap152.62B
Intuitive Surgical competes in the surgical space with robotic systems that, while not directly radiation therapy, offer alternative treatments for conditions Elekta's products also address.
Boston Scientific
BSX
Mkt Cap60.84B
Boston Scientific competes in the medical device market, particularly in neuromodulation, where its products can be seen as alternatives to Elekta's for certain conditions.
Smith & Nephew
SNN
Mkt Cap12.43B
Smith & Nephew competes in the advanced wound management and surgical devices market, indirectly competing with Elekta's offerings in surgical and oncology care.
Zimmer Biomet
ZBH
Mkt Cap18.03B
Zimmer Biomet competes in the musculoskeletal healthcare market, including surgical solutions that can indirectly compete with Elekta's products for certain therapeutic and diagnostic applications.
Stryker
SYK
Mkt Cap111.95B
Stryker competes across several medical device markets, including neurotechnology and spine, where its products can compete with Elekta's neurosurgical and radiosurgery offerings.
Globus Medical
GMED
Mkt Cap10.48B
Globus Medical competes in the spine and neurosurgery markets with products that can be alternatives to Elekta's solutions for spinal and brain conditions.
Abbvie
ABBV
Mkt Cap521.11B
AbbVie, through its acquisition of Allergan, competes in the neuroscience space, offering pharmaceutical alternatives to Elekta's device-based treatments for neurological conditions.
Johnson & Johnson
JNJ
Mkt Cap657.68B
Johnson & Johnson, through its medical devices division, competes in several areas including surgery and oncology, offering products that can be seen as alternatives to Elekta's radiation therapy and neurosurgery devices.

About

Elekta AB (publ) operates as a global medical technology company, delivering advanced clinical solutions for managing cancer and various brain disorders. Its extensive oncology offerings include sophisticated radiation therapy systems such as Versa HD, tailored for brain metastases; the groundbreaking Elekta Unity, leveraging MR-Linac technology; linear accelerators like Elekta Harmony; and Elekta Infinity, designed to address diverse radiotherapy needs. The company also provides Elekta Synergy, a digital accelerator for advanced image-guided radiation therapy. Beyond primary treatment devices, Elekta supplies comprehensive treatment management solutions, automated and integrated quality assurance tools, and hardware/software for motion management. Specialized oncology platforms feature MOSAIQ Plaza for multidisciplinary cancer care, the managed hosting service Elekta Axis Cloud, and Elekta Studio for image-guided brachytherapy. Complementary hardware includes the ImagingRing mobile CT scanner. For brachytherapy, they offer smart tools like Oncentra Brachy to streamline repetitive tasks, alongside applicators such as Venezia and Geneva for cervical cancer treatment, and the Elekta Flexitron afterloader for precise workflow execution. In the field of neurosurgery and radiosurgery, Elekta provides the Leksell Gamma Knife series, including Icon for personalized radiation treatment, Perfexion as a vital tool for neurosurgeons, and Lightning for accelerated radiosurgery. Their neurosurgery product line further encompasses the Leksell Vantage Stereotactic System for intracranial procedures and the Leksell Stereotactic System for minimally invasive interventions. Elekta AB (publ) was founded in 1972 and is headquartered in Stockholm, Sweden.
Show More
CEO
Jakob Just-Bomholt
Employees
3996
Country
Sweden
ISIN
SE0000163628
WKN
000896279

Listings

0 Comments

Share your thoughts

FAQs

What is Elekta AB stock price today?▼
The current price of EJXB.MU is €5.50 EUR — it has decreased by -0.18% in the past 24 hours. Watch Elekta AB stock price performance more closely on the chart.
What is Elekta AB stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Muenchen exchange Elekta AB stocks are traded under the ticker EJXB.MU.
Is Elekta AB stock price growing?▼
EJXB.MU stock has risen by +3.87% compared to the previous week, the month change is a +16.92% rise, over the last year Elekta AB has showed a +39.52% increase.
What is Elekta AB market cap?▼
Today Elekta AB has the market capitalization of 2.03B
When is the next Elekta AB earnings date?▼
Elekta AB is going to release the next earnings report on November 25, 2026.
What were Elekta AB earnings last quarter?▼
EJXB.MU earnings for the last quarter are 0.06 EUR per share, whereas the estimation was 0.04 EUR resulting in a +47.97% surprise. The estimated earnings for the next quarter are N/A EUR per share.
What is Elekta AB revenue for the last year?▼
Elekta AB revenue for the last year amounts to 1.54B EUR.
What is Elekta AB net income for the last year?▼
EJXB.MU net income for the last year is -47.55M EUR.
Does Elekta AB pay dividends?▼
Yes, EJXB.MU dividends are paid semi-annual. The last dividend per share was 0.11 . As of today, Dividend Yield (FWD)% is 3.94%.
How many employees does Elekta AB have?▼
As of November 7, 2026, the company has 3,996 employees.
In which sector is Elekta AB located?▼
Elekta AB operates in the Health & Wellness sector.
When did Elekta AB complete a stock split?▼
The last stock split for Elekta AB was on September 12, 2012 with a ratio of 4:1.
Where is Elekta AB headquartered?▼
Elekta AB is headquartered in Stockholm, Sweden.